Butalid, Resciel C.
HRN: 27-65-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2025
CEFUROXIME 1.5GM (VIAL)
10/05/2025
10/06/2025
IVT
1.5GMS
ON CALL TO OR THEN Q8 HOURS
LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes